Treating Afib: AV Node Ablation a ‘Last Resort’

A U-M cardiologist and arrhythmia expert explains Afib treatment options.

12:14 AM

Author | Jane Racey Gleeson

If you have a diagnosis of atrial fibrillation (frequently abbreviated as Afib), you've likely discussed with your doctor and possibly tried a variety of treatment options, including aspirin, warfarin or novel oral anticoagulant drugs.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

For Afib patients for whom blood thinners pose a risk, the recommended treatment may be a mechanical umbrella shape device (Watchman). The device closes off the left atrial appendage, where blood clots tend to develop, thereby eliminating the need for long-term anticoagulation medication.

With these treatments, the first goal for Afib patients is to prevent thromboembolic complications, particularly stroke, according to Hakan Oral, M.D., of the University of Michigan Frankel Cardiovascular Center.

"This involves a careful and comprehensive assessment of the patient's individual risk for stroke and choosing the appropriate approach," he says.

Then, treatment turns to improving symptoms and quality of life as well as a potential improvement in heart function, Oral says.

"This often involves a 'rhythm control' strategy," says Oral, "meaning that normal sinus rhythm is restored and maintained either by using specific antiarrhythmic drugs, or by catheter ablation when the antiarrhythmic drugs are ineffective, not tolerated, contraindicated or not preferred by the patient."  

Catheter ablation is a minimally invasive technique intended to treat atrial fibrillation without major surgery. Catheters (thin, flexible wires) are put into a blood vessel in the arm, groin or neck and are guided into the heart through the blood vessel.

A special machine sends energy to the heart through one of the catheters to burn the "short circuits" in the heart that are generating the atrial fibrillation. The procedure often involves radiofrequency energy to produce heat that destroys tiny areas of heart tissue involved in the abnormal heart rhythm.

The U-M team has had much success with catheter ablation treatment, which has resulted in improved quality of life for patients. For 70 to 75 percent of patients with paroxysmal atrial fibrillation (the type that comes and goes on its own), Afib is eliminated with a single procedure. When the procedure is repeated in patients who still have atrial fibrillation after the first procedure, the overall success rate is about 85 to 90 percent.

At U-M, we focus on choosing the most appropriate treatment strategy for the right patient. … A comprehensive and detailed evaluation is the key.
Hakan Oral, M.D.

Second-line treatments

"When rhythm control is not feasible, then we often resort to a 'rate control' strategy," says Oral.

Rate control can be achieved with medicines called beta blockers, calcium channel blockers or digoxin, alone or in combination. But for some patients, drugs are insufficient or not well tolerated.

In these cases, an AV node ablation and pacemaker implantation procedure is considered "as the last resort," Oral says, for only patients with the most serious symptoms or those with deteriorated heart function because of rapid heart rate.

"With AV node ablation, the group of cells that transmit electrical signals from the upper chambers of the heart [atria where atrial fibrillation occurs] to the lower main pumping chambers that generate the pulse [ventricles] is intentionally damaged by catheter ablation," he explains. After AV node ablation, a pacemaker is necessary as the heart rate would otherwise be very slow.

"At U-M, we focus on choosing the most appropriate treatment strategy for each patient," Oral says. "We've found that controlling the rhythm often results in a better quality of life for our patients; however, in a subgroup of patients, rate control is the right choice. A comprehensive and detailed evaluation is the key."

More Articles About: Heart Health Atrial fibrillation (Afib) Interventional cardiology Cardiovascular: Diseases & Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories
Health Lab
After Catheter Ablation for Afib, Recovery — and a Return to the Water
A U-M doctor suffering from an arrhythmia, intermittent atrial fibrillation, received a catheter ablation. See how the procedure helped his irregular heartbeat.
Health Lab
Catheter Ablation Helps Homebody Return to Adventure-Seeking Ways
Atrial tachycardia and atrial fibrillation patient Mike Penskar is enjoying life after a catheter ablation procedure. Learn more about Mike and the procedure.
Health Lab
Second Time’s the Charm with Catheter Ablation
Cardiac catheter ablation, a minimally invasive procedure to treat atrial fibrillation, also know as A Fib, help a 61-year-old ice skater get off of thin ice and back in the rink.
person in white coat at laptop green fruit in hand
Health Lab
Both virtual and in-person nutrition visits help to lower cholesterol
The use of telehealth remains high, with over 20% of American adults taking appointments online. These visits include video calls with registered dietitian nutritionists, who have a critical role in helping patients take on lifestyle changes through medical nutrition therapy. With a focus on the changing digital landscape, researchers at Michigan Medicine found that telemedicine patients with hyperlipidemia — an excess of cholesterol or fats in the blood — experienced similar positive health benefits compared to those who had in-person visits.
smart watch on wrist
Health Lab
Clinical smart watch finds success at identifying atrial fibrillation
A Michigan Medicine research team developed a prescription wristwatch that continuously monitors the wearer’s heart rhythm and uses a unique algorithm to detect atrial fibrillation. The clinical-grade device, called the Verily Study Watch, proved very accurate at identifying atrial fibrillation in participants.
supar molecule teal blue yellow red
Health Lab
Immune protein suPAR links viral infection as possible cause of kidney disease
Through a series of experiments in non-human primates, mice and humans, a multi-institutional team led by researchers from Michigan Medicine and Rush University found that the immune protein soluble urokinase plasminogen activator receptor, or suPAR, is an important link between viral infections and proteinuria; the elevation of protein in the urine is known to cause glomerulopathy, a common form of kidney disease.